WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...
Researchers provided comprehensive evidence of the benefits of statin use in elderly patients, addressing longstanding uncertainties. The robust evidence demonstrated that continuous statin therapy ...
Dear Dr. Roach: A cardiologist recently suggested that I should consider taking a statin because of my “borderline” cholesterol level. So, I took a dive into the details of statin therapy. I learned ...
Successful topline results from the CLEAR Outcomes Trial demonstrate that bempedoic acid, marketed as NILEMDO ® in Europe, reduces the risk of serious cardiovascular (CV) events in patients with, or ...
Dear Dr. Roach: A cardiologist recently suggested that I should consider taking a statin because of my “borderline” cholesterol level. So, I took a dive into the details of statin therapy. I learned ...
INGELHEIM, Germany and INDIANAPOLIS--(BUSINESS WIRE)--Full results from the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with and without diabetes, ...
The recently published results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial [1] showed that high-dose statin therapy could significantly reduce the risk of ...
New Delhi, 2025: Considering the increasingly diverse development of tobacco products, the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback